ImmunoGenesis
PrivateLast Round
Grant
Dec 4, 2025
Total Funding Raised
$70.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ImmunoGenesis is a biopharmaceutical company that develops immuno-oncology therapeutics designed to enhance immune responses in cold tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoGenesis Comparables
Compare ImmunoGenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incendia Therapeutics | 87% | |
| BioEclipse Therapeutics | 79% | |
| 7 Hills Pharma | 79% | |
ImmunoGenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 4, 2025 | ||||
| Series A | Apr 1, 2024 | ||||
| VC Round | Jun 27, 2023 | ||||
| Grant | Aug 19, 2020 |
ImmunoGenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The University of Texas MD Anderson Cancer Center | VC Round |
| Cancer Focus Fund | Series A, VC Round |
| Cancer Prevention and Research Institute of Texas (CPRIT) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 55% MoM.
- Apr 15, 2026
Poster presentation at the AACR 2026 Annual Meeting.
ImmunoGenesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmunoGenesis's valuation, stock price, and market status.